Clinical Trial Update: Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of choline alfoscerate in patients with Alzheimer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Choline alfoscerate (choline alfoscerate)

Snippet

Sponsor: Daewoong Bio Inc. | Conditions: Alzheimer Disease | Phase 4 | Status: UNKNOWN